News

News
January 24, 2012

BL-8020 exclusive License Agreement with BioLineRx

BioLineRx signs exclusive License Agreement for BL-8020, an oral Hepatitis C treatment   Jerusalem, Israel,…
Read More
News
June 19, 2007

Joint Venture Agreement with RFS Pharma

RFS Pharma and Genoscience Pharma Sign Joint Venture Agreement to Discover and Develop Protease Inhibitors…
Read More